Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2026 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
2026 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2026 · first_quarter · Q1
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2025 · fourth_quarter · Q4
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2025 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2025 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2025 · first_quarter · Q1
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2024 · fourth_quarter · Q4
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2024 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2024 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2024 · first_quarter · Q1
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2023 · fourth_quarter · Q4
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2023 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2023 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2023 · first_quarter · Q1
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2022 · fourth_quarter · Q4
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2022 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2022 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2022 · first_quarter · Q1
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2021 · fourth_quarter · Q4
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2021 · third_quarter · Q3
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2021 · second_quarter · Q2
On behalf of client support continued and future funding for clinical research programs in Arkansas
On behalf of client support continued and future funding for clinical research programs in Arkansas
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARKANSAS RESEARCH ALLIANCE via IMPACT MANAGEMENT GROUP
2021 · second_quarter · RR
ARA supports continued and future funding for clinical research programs in Arkansas
ARA supports continued and future funding for clinical research programs in Arkansas
DUCTILE IRON PIPE RESEARCH ASSOCIATION via IMPACT MANAGEMENT GROUP
2020 · third_quarter · 3T
Water Infrastructure Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DUCTILE IRON PIPE RESEARCH ASSOCIATION via IMPACT MANAGEMENT GROUP
2020 · third_quarter · RA
Water infrastructure funding